Micrus News

McNeil Consumer Healthcare, a Fort Washington-based subsidiary of Johnson & Johnson announced on May 17 that it has recalled Imodium Multi-Symptom Relief , 18 Caplets.

Diego Solimano, the lawyer for plaintiff Karen Dyler, says two groups of women - elderly women and woman who have given birth to children - are most affected by incontinence.

"We appreciate the thoroughness of the committee's review, and will ensure the questions raised today are addressed with the FDA," said XARELTOA is approved in the U.S. to reduce the risk of blood clots in the legs and lungs of people who have just had knee or hip replacement surgery, and to reduce the risk of both hemorrhagic and thrombotic ... (more)

Johnson and Johnson headquarters in New Brunswick, which is cheaper than the northern New Jersey area for corporate headquarters, but still among the more expensive locations nationally.

On Tuesday there were a number of articles proclaiming that Johnson & Johnson is a buy right now; that the stock is due for a rebound; and that the dividend makes for a solid income play.

NEW YORK -- The following stocks go ex-dividend Thursday, meaning an investor must purchase the shares Wednesday to qualify for the next dividend payment: Johnson & Johnson "We believe JNJ's business is starting to turn the corner from many of the challenges of 2010 and expect the pipeline to deliver accelerating growth," Wells Fargo analysts wrote ... (more)

Johnson & Johnson is struggling but we do not think the stock will stay down for a long period of time.

DePuy's products are primarily used by orthopaedic specialists and spinal neurosurgeons to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, trauma and sports-related injuries.

Healthy men shouldn't get routine prostate cancer screenings, says updated advice from a government panel that found the PSA blood tests do more harm than good.

Johnson and Johnson is at the lower end of a trading range which began late August 2011.

DaVita acquires private equity HealthCare Partners for approximately $4.42 billion in cash and stock.

The Food and Drug Administration said Monday that a blood thinner from Johnson & Johnson appears to reduce life-threatening blood clots in high-risk patients, although it also increases the risk of internal bleeding.

The Food and Drug Administration says a blood thinner from Johnson & Johnson appears to reduce life-threatening blood clots in high-risk patients, although it also increases the risk of internal bleeding.

The group also has a Veterinary business. Synthes Trauma - produces plate and screw systems, intramedullary nailing systems and external fixation devices that are used for the surgical treatment of fractures, deformities and tumour diseases of long bones.

A Johnson & Johnson executive at IAB's Innovation Day conference this week said that although mobile is being tapped as a promotional tool, it is best used as a strategic tactic in emerging markets.

Dendreon is getting slammed after it became known the SEC is investigating the company.

It's spelled D-U-C-T, not D-U-C-K, right? Not so fast. As I was researching the origins of this ubiquitous and arguably the most useful product known to humanity, I stumbled upon the most interesting facts.

However, that's the combined average 2012 dividend income increase from five of some of the strongest dividend payers around.

Jordo is a member of The Motley Fool Blog Network -- entries represent the personal opinions of our bloggers and are not formally edited.

Achillion's early stage-trial hepatitis C drug ACH-3102 gets fast-track status from the FDA.